Abstract Synthesis of new and desired compounds has an everlasting demand. The present work emphasizes on the one pot, three component microwave assisted synthesis of novel ethyl 2-methyl-4-(pyridin-2-yl)-4H-benzo [4,5]thiazolo[3,2-a]pyrimidine-3-carboxylate derivatives by the reaction of 2-aminobenzothiazole derivatives with Pyridine 2-aldehyde and Ethyl acetoacetate in the presence of PdCl 2 as an expeditious catalyst under solvent-free condition. The salient features of this approach are operational simplicity, convergence, short reaction time, high atom economy, easy workup, mild reaction conditions and environmentally benign conditions. All the newly synthesized diverse poly-functionalized tri-heterocyclic benzothiazole derivatives have been characterized by elemental analysis and various spectroscopic methods such as FT-IR, 1
Introduction
Search on efficient organic synthesis approach that substantiates the rapid generation of complex organic molecules from simple and readily accessible starting materials is in vogue during recent epochs and the interests have been engrossed a current position (Chow and Shea, 2005; de Graaff et al., 2012; Jiang et al., 2010; Shiri, 2012) . The important medicinal compounds, which are synthesized through steadfast reactions are receiving more fascinating attention. Literature shows that scientists have also eventually facilitated the rapid development of new chemical entities which are available for biological evaluation.
Non-traditional conditions and their approach to implement new synthetic organic reactions have gained popularity, primarily to circumvent growing environmental concerns (Pillai et al., 2002; Raghavendra et al., 2007) . Microwave assisted reaction is an invaluable technology for synthesis of organic compounds with respect to time as it decelerates reaction time with enhanced yields and selectivity. Microwave reaction under solvent free conditions is consensus in offering reduced pollution with ease in processing and handling (Bejan et al., 2012; de la Hoz et al., 2005; Desai et al., 2006; Hayes, 2002 Hayes, , 2004 Kappe, 2000 Kappe, , 2004 Kappe, , 2008 Kappe et al., 2012; Khabazzadeh et al., 2008; Perreux and Loupy, 2002; Stadler et al., 2002 Stadler et al., , 2003 .
The chemistry of fused heterocycles is known to fascinate field of investigation in therapeutic chemistry, since they have been found to display improved biological activity. Heterocyclic compounds show significant role in both medicinal chemistry and their constitution in natural products. Among them, benzothiazole derivatives have received substantial attention in synthetic organic chemistry with numerous significant and valuable applications in the pharmaceutical industry. From the current literature survey, benzothiazole derivatives have shown various biological activities (Bhoi et al., 2015a (Bhoi et al., , 2015b (Bhoi et al., , 2014 Boer and Gekeler, 1995; Borad et al., 2015; Bretzel et al., 1993; Hutchinson et al., 2001; Klusa, 1995; Pande et al., 1982; Singh et al., 1975; Singh and Vaid, 1986; Huang and Yang, 2006; Jiang et al., 2009 Jiang et al., , 2011 Wu et al., 2014a Wu et al., , 2014b Yang et al., 2013; Zuo et al., 2012) used in material science and in other industrial applications (Choudhary et al., 2013; Hopper, 1993; Zhang et al., 2001) . The important and pharmacological properties of benzothiazole derivatives along with their improved synthetic methods allow a facile access to these heterocyclic compounds. Recently, many efforts have been dedicated to improve new and highly effective synthetic protocols such as [3 + 2] cycloadditions, transition metal catalyzed cyclization and multicomponent coupling reactions for the synthesis of derivatives of benzothiazole (Bastug et al., 2012; Jaseer et al., 2010; Karle et al., 2012; Noolvi et al., 2012; Sahu et al., 2012a; Tale, 2002; Trapani et al., 1996; Xue et al., 2013) . Typically, multi-component reactions (MCRs) are an influential tool which attract much more focus in synthetic organic reactions owing to the complex molecules with varied range of complexity where the starting materials are easily available (Benetti et al., 1995; Do¨mling, 2006; Kappe, 2002; Langer, 2001; Nair et al., 2003; Ramo´n and Yus, 2005; Simon et al., 2004) . Thus, MCRs are influenced by microwave and solvent free condition as a powerful green alternative over the conventional synthesis (Devineni et al., 2013; Eynde et al., 2001; Kappe, 2000 Kappe, , 2002 Kappe and Stadler, 2004; Leadbeater et al., 2006; Oliver Kappe, 1993; Saxena and Chandra, 2011) .
The Biginelli reaction is recognized multicomponent reaction for the synthesis of 4H-pyrimido [2,1-b] benzothiazoles and associated polyheterocycles (Chebanov et al., 2010; Ranu et al., 2000; Sedash et al., 2012) . Since 1893, a one pot, three-component condensation reaction between aldehyde, b-ketoesters and urea was first time reported by Biginelli (Biginelli and Gazz, 1893) to produce 3,4-dihydropyrimidin-2-(1H)one.
Compound 2-amino benzothioazoles and 2-aminobenzimidazoles derivatives are used in place of urea (Alajarin et al., 1995; Shaabani et al., 2005) . The Biginelli reaction can be carried out by heating as well as by acid and base catalysts. Recently, catalysts such as FeF 3 (Atar and Jeong, 2014) , Kaolin (Sahu et al., 2013) , N,N-dichlorobis(2,4,6-trichlorophenyl)urea (Rao et al., 2011) , hydrotalcite (Sahu et al., 2012b) , TBAHS (Nagarapu et al., 2013) , AlCl 3 (Sahu et al., 2012c) , and Zn(ClO 4 ) 2 Á6H 2 O (Kaur et al., 2015; Singh et al., 2013 ) have shown to be effective for the synthesis of 4H-pyrimido[2,1-b]benzothiazoles. Although these methods afford good results, there is yet a great demand for quick and ecofriendly catalytic MCRs conditions. Our aim is to find out the best environmental friendly catalytic system for a one-pot reaction through microwave assisted synthesis under solvent free condition.
Encouraged by the auspicious biological activity of the structurally diverse heterocycles with fused heterocyclic systems and our continuing research plan on the synthesis of therapeutically interesting heterocycles, we have developed new structural motifs with promising bioactivity. An efficient, one pot three component synthesis of ethyl 2-methyl-4-(pyridin-2-yl)-4H-benzo [4, 5] thiazolo[3,2-a] pyrimidine-3-carboxylate derivatives by reaction between various derivatives of 2-amino-benzothiazole with Pyridine 2-aldehyde and Ethyl acetoacetate using PdCl 2 as an efficient catalyst under microwave assisted solvent-free conditions, with better yield and short reaction time is introduced to develop new structural motifs with promising bioactivity. We have evaluated their antibacterial activity against gram +ve and gram Àve bacterial strains and antitubercular activity against Mycobacterium tuberculosis H 37 RV and also screened antioxidant activity.
Material and methods

Chemistry
All chemicals and solvents were acquired from commercial sources (Aldrich-Sigma and Merck chemical suppliers). The reactions were scrutinized by thin layer chromatography (TLC) and judged by the consumption of starting material. TLC was performed on silica gel G 60 F 254 (Merck) plate. It was visualized by UV radiation, exposure to iodine vapor and spray reagent also. Column chromatography was conducted over silica gel 60 (60-120 lm). CEM Discover microwave system (model No.: 908010; make up CEM Matthews. Inc, USA) was used for synthesis with external IR temperature control. The melting points recorded on optimelt automated melting point system were uncorrected. IR spectra were recorded on a Perkin-Elmer 377 spectrophotometer in KBr with absorption in cm
À1
.
1 H NMR and 13 C NMR spectra were recorded on Bruker AV 400 and 100 MHz using DMSO-d 6 as solvent and TMS as an internal standard. Mass spectra were recorded on Advion Expression CMS, USA, using Methanol:Water:Formic acid (80:20:0.1) as mobile phase. Elemental analysis was performed on vario MICRO cube, elementar CHNS analyser serial No.: 15084053. Single crystal X-ray diffraction intensity data of the compound 4a were collected on an Oxford XCALIBUR-S CCD diffractometer with Cu Ka radiation (k = 1.54184 Å ) at 195(100) K.
Synthesis of ethyl-
Mixture of pyridine 2-aldehydes 1 (4.668 mmol), b-diketone like Ethyl acetoacetate 2 (4.668 mmol) and various derivatives of 2-amino benzothiazole 3a-3l (4.668 mmol) in 10 ml microwave open vessel glass tube was placed in the cavity of a microwave oven (CEM Discover microwave) and irradiated for 2-5 min at 90°C under solvent-free conditions by using PdCl 2 (10 mol%) as a catalyst with continuous monitoring of the reaction by TLC (30% Ethyl acetate: hexane). After completion of the reaction, the reaction mixture was cooled to room temperature and then poured into ice-water by solubilizing in ethanol solvent. The precipitated solid was filtered, and subjected to column chromatography using 20% (v/v) Ethyl acetate : hexane mixture as an eluent to afford ethyl-(s ubstituted)-2-methyl-4-(pyridin-2-yl)-4H-benzo [4, 5] thiazolo[3,2-a]pyrimidine-3-carboxylate (4a-4l) as pure product with 77-88% yield.
Method B (conventional method)
As mentioned in above method same chemical ratio was taken in a 25 ml round bottom flask. Resulting mixture was placed in oil bath for 20-70 min at 90°C under solvent-free conditions using PdCl 2 (10 mol%) as a catalyst. The time taken by different derivatives of 2-amino benzothiazole in the reaction is shown in Table 3 . After confirmation of each reaction using TLC (30% Ethyl acetate: hexane), the reaction mixture was allowed to cool at room temperature and poured in cold water after solubilizing in ethanol solvent with a requisite volume. The mixture was filtered continuously giving a wash of water. The solid crude product was simply purified by column chromatography over silica gel using solvent system (20% ethyl acetate: hexane) as an eluent to obtain subsequent pure product (4a-4l) with 69-80% yield. 42, 166.12, 160.08, 157.22, 146.82, 141.40, 139.47, 127.91, 127.44, 127.15, 124.57, 121.61, 114.02, 107.69, 61.50, 55.90, 18.12, 14.70 H, 3.75; Br, 18.57; N, 9.76; O, 7.44; S, 7.45%; found C, 53.22; H, 3.55; N, 9.58; S, 7 dd, J = 7.5, 1.4 Hz, C 6 AH), 7.77 (1H, td, J = 7.4, 1.4 Hz, C 8 AH), 7.72-7.62 (2H, m, C 9&4 AH), 7.33 (1H, td, J = 7.4, 1.5 Hz, C 7 AH), 7.19 (1H, dd, J = 7.5, 1.6 Hz, C 2 AH), 6.47 (1H, d, J = 7.5 Hz, C 1 AH), 5.74 (1H, s, C 5 AH), 4.25 (2H, q, J = 5.9 Hz, ACH 2 ), 2.21 (3H, s, ACH 3 ), 1.36 (3H, t, J = 5.9 Hz, ACH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166. 42, 166.12, 160.08, 157.22, 146.82, 143.49, 139.47, 128.82, 127.91, 126.10, 124.22, 123.54, 121.56, 115.45, 107.69, 61.50, 55.90, 18.12, 14.70 42, 166.12, 160.08, 157.22, 146.82, 140.75, 139.47, 135.27, 128.24, 127.91, 124.00, 122.43, 121.56, 112.72, 107.69, 61.50, 55.90, 21.21, 18.12, 14.70 1 H NMR (400 MHz, DMSO) d 8.61 (1H, dd, J = 7.5, 1.4 Hz, C 6 AH), 7.71 (2H, dtd, J = 8.9, 7.5, 1.4 Hz, C 8&9 AH), 7.43-7.22 (2H, m, C 4&7 AH), 6.88 (1H, dd, J = 7.5, 1.4 Hz, C 2 AH), 6.67 (1H, t, J = 7.5 Hz, C 3 AH), 5.94 (1H, s, C 5 AH), 4.24 (2H, q, J = 5.9 Hz, ACH 2 ), 2.38 (3H, s, C 1 -CH 3 ), 2.11 (3H, s, ACH 3 ), 1.37 (3H, t, J = 5.9 Hz, ACH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166.11, 160.08, 157.22, 146.82, 139.50, 130.19, 128.61, 127.91, 127.02, 121.56, 118.62, 118.08, 107.69, 61.5, 55.58, 18.07, 14.70 ; ESI-MS: m/z calculated 365.45, found [M+H] + 366.4. 1 H NMR (400 MHz, DMSO) d 8.61 (1H, dd, J = 7.5, 1.4 Hz, C 6 AH), 8.41 (1H, d, J = 1.4 Hz, C 4 AH), 7.97 (1H, dd, J = 7.5, 1.4 Hz, C 2 AH), 7.77 (1H, td, J = 7.5, 1.4 Hz, C 8 AH), 7.59 (1H, dd, J = 7.5, 1.6 Hz, C 9 AH), 7.33 (1H, td, J = 7.5, 1.4 Hz, C 7 AH), 6.85 (1H, d, J = 7.5 Hz, C 1 AH), 5.57 (1H, s, C 5 AH), 4.23 (2H, q, J = 5.9 Hz, ACH 2 ), 2.18 (3H, s, ACH 3 ), 1.37 (3H, t, J = 5.9 Hz, ACH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166. 42, 166.12, 160.08, 157.22, 147.15, 146.82, 145.82, 139.47, 133.29, 127.91, 123.63, 121.56, 115.53, 112.10, 107.69, 61.50, 55.90, 18.12, 14.70 1 H NMR (400 MHz, DMSO) d 8.67 (1H, dd, J = 7.5, 1.4 Hz, C 6 AH), 7.77 (1H, td, J = 7.4, 1.4 Hz, C 8 AH), 7.68 (1H, dd, J = 7.5, 1.4 Hz, C 9 AH), 7.49 (1H, d, J = 1.6 Hz, C 4 AH), 7.33 (1H, td, J = 7.4, 1.5 Hz, C 7 AH), 7.03 (1H, dd, J = 7.5, 1.4 Hz, C 2 AH), 6.52 (1H, d, J = 7.5 Hz, C 2 AH), 5.75 (1H, s, C 5 AH), 4.25 (2H, q, J = 5.9 Hz, ACH 2 ), 2.21 (3H, s, ACH 3 ), 1.36 (3H, t, J = 5.9 Hz, ACH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166. 42, 166.12, 160.08, 157.22, 146.82, 141.00, 139.47, 132.27, 129.15, 127.91, 127.13, 121.56, 120.29, 117.30, 107.69, 61.50, 55.90, 18.12, 14.70 1 H NMR (400 MHz, DMSO) d 8.70 (1H, dd, J = 7.5, 1.4 Hz, C 6 AH), 7.72 (2H, dtd, J = 9.1, 7.5, 1.5 Hz, C 8&9 AH), 7.44-7.25 (2H, m, C 4&7 AH), 7.04 (1H, dd, J = 7.5, 1.4 Hz, C 2 AH), 6.67 (1H, t, J = 7.5 Hz, C 3 AH), 6.29 (1H, s, C 5 AH), 4.23 (2H, q, J = 5.9 Hz, ACH 2 ), 2.40 (3H, s, ACH 3 ), 1.36 (3H, t, J = 5.9 Hz, ACH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166.11, 160.08, 157.22, 146.82, 139.47, 137.37, 129.08, 128.21, 127.91, 125.88, 123.72, 121.56, 121.02, 107.69, 61.50, 55.58, 18.12, 14.70 ; ESI-MS: m/z calculated 385.87, found [M+H] + 386.8. H NMR (400 MHz, DMSO) d 8.65 (1H, dd, J = 7.5, 1.4 Hz, C 6 AH), 7.74 (1H, td, J = 7.5, 1.5 Hz, C 8 AH), 7.62 (1H, dd, J = 7.5, 1.4 Hz, C 9 AH), 7.33 (1H, td, J = 7.5, 1.5 Hz, C 7 AH), 7.20 (1H, dd, J = 8.1, 1.4 Hz, C 4 AH), 6.78 (1H, td, J = 7.9, 1.5 Hz, C 2 AH), 6.61 (1H, dd, J = 7.5, 5.1 Hz, C 1 AH), 6.00 (1H, s, C 5 AH), 4.23 (2H, q, J = 5.9 Hz, ACH 2 ), 2.44 (3H, s, ACH 3 ), 1.36 (3H, t, J = 5.9 Hz, ACH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166. 42, 166.12, 160.08, 159.48, 157.22, 146.82, 139.47, 138.13, 128.01-127.80, 121.56, 117.98, 115.88, 110.25-110.05, 107.69, 61.50, 55.90, 18.12, 14.70 1 H NMR (400 MHz, DMSO) d 8.60 (1H, dd, J = 7.5, 1.4 Hz, C 6 AH), 7.77 (1H, td, J = 7.5, 1.5 Hz, C 8 AH), 7.68 (1H, dd, J = 7.5, 1.4 Hz, C 9 AH), 7.33 (1H, td, J = 7.5, 1.6 Hz, C 7 AH), 7.06 (1H, d, J = 1.4 Hz, C 4 AH), 6.62 (1H, dd, J = 7.5, 1.4 Hz, C 2 AH), 6.52 (1H, d, J = 7.5 Hz, C 1 AH), 5.73 (1H, s, C 5 AH), 4.23 (2H, q, J = 5.9 Hz, ACH 2 ), 3.80 (3H, s, AOCH 3 ), 2.58 (3H, s, ACH 3 ), 1.36 (3H, t, J = 5.9 Hz, ACH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166. 42, 166.12, 160.08, 157.59, 157.22, 146.82, 139.47, 136.72, 127.91, 127.49, 121.56, 118.44, 114.13, 111.15, 107.69, 61.50, 55.97, 18.12, 14.70 1 H NMR (400 MHz, DMSO) d 8.66 (1H, dd, J = 7.5, 1.4 Hz, C 6 AH), 7.76 (1H, td, J = 7.5, 1.4 Hz, C 8 AH), 7.62 (1H, dd, J = 7.5, 1.4 Hz, C 9 AH), 7.33 (1H, td, J = 7.4, 1.5 Hz, C 7 AH), 7.06 (1H, d, J = 1.4 Hz, C 4 AH), 6.62 (1H, dd, J = 7.5, 1.4 Hz, C 2 AH), 6.53 (1H, d, J = 7.4 Hz, C 1 AH), 5.63 (1H, s, C 5 AH), 4.21 (2H, q, J = 5.9 Hz, ACH 2 ), 4.03 (2H, q, J = 5.9 Hz, AOCH 2 ), 2.41 (3H, s, ACH 3 ), 1.35 (6H, dt, J = 31.7, 5.9 Hz, -2CH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166. 42, 166.12, 160.08, 157.29, 146.82, 139.47, 136.46, 127.91, 127.11, 121.56, 118.40, 115.70, 112.52, 107.69, 63.99, 61.50, 55.90, 18.12, 14.70, 13.83 H NMR (400 MHz, DMSO) d 8.60 (1H, dd, J = 7.5, 1.4 Hz, C 6 AH), 7.75 (2H, dtd, J = 9.1, 7.5, 1.5 Hz, C 8&9 AH), 7.42-7.23 (1H, m, C 7 AH), 7.09 (1H, d, J = 1.4 Hz, C 4 AH), 6.74 (1H, dd, J = 7.5, 1.6 Hz, C 2 AH), 6.59 (1H, d, J = 7.5 Hz, C 1 AH), 5.63 (1H, s, C 5 AH), 4.25 (2H, q, J = 5.9 Hz, ACH 2 ), 2.58 (3H, s, ACH 3 ), 1.36 (3H, t, J = 5.9 Hz, ACH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166. 42, 166.12, 160.08, 157.22, 149.85, 146.82, 139.47, 131.49, 127.91, 125.37, 122.75, 122.34, 121.56, 114.16, 107.69, 61.50, 55.90, 18.12, 14.70 1 H NMR (400 MHz, DMSO) d 8.59 (1H, dd, J = 7.5, 1.4 Hz, C 6 AH), 7.77 (1H, td, J = 7.4, 1.4 Hz, C 8 AH), 7.69 (1H, dd, J = 7.5, 1.6 Hz, C 9 AH), 7.33 (1H, td, J = 7.5, 1.5 Hz, C 7 AH), 6.95 (1H, d, J = 1.4 Hz, C 4 AH), 6.59-6.49 (2H, m, C 1&2 AH), 5.97 (1H, s, C 5 AH), 4.81 (1H, s, AOH), 4.24 (2H, q, J = 5.9 Hz, ACH 2 ), 2.23 (3H, s, ACH 3 ), 1.35 (3H, t, J = 5.9 Hz, ACH 3 ); 13 C NMR (100 MHz, DMSO-d 6 ) d 166. 42, 166.12, 160.08, 157.22, 154.78, 146.82, 139.47, 134.83, 127.91, 126.04, 121.56, 118.57, 113.55, 111.39, 107.69, 61.50, 55.90, 18.12, 14.70 ; ESI-MS: m/z calculated 367.10, found [M+H] + 368.1. The volume of test culture was 0.1 ml whose optical density is equal to 0.235 at 750 nm and was allowed to solidify. Wells with 5 mm diameter were prepared at equal distance in solidified agar plates using cup-borer. Various derivatives 4a-4l with 1000 lg/ml concentration were inoculated in the wells of nutrient agar whereas test microorganisms were inoculated by pour plate technique. The plates were incubated at 37°C for 24 h. The inhibition zones were measured at the end of the incubation period and were compared and envisaged with positive and negative controls where streptomycin (1000 lg/ml) is a standard taken and the drug was dissolved in 95% DMF.
Determination of antibacterial activity
Antioxidant assay protocol
Each sample was dissolved in 95% DMF to make a concentration of 1 mg/ml and then diluted to prepare a series of concentrations for antioxidant assays. Reference chemicals were used for comparison in all assays.
DPPH radical scavenging activity assay
The free radical scavenging activity of the 4a-4l was measured in vitro by 2,2 0 -diphenyl-1-picrylhydrazyl (DPPH) assay according to the method described by Brand-Williams et al. (1995) . The stock solution was prepared by dissolving 24 mg DPPH with 100 ml methanol and stored at 20°C as required. The working solution was obtained by diluting DPPH solution with DMF to attain an absorbance of about 0.98 ± 0.02 at 517 nm using the spectrophotometer. A 3 ml aliquot of this solution was mixed with 100 ll of the sample at various concentrations (0-600 lg/ml) as shown in Table 5 . The reaction mixture was shaken well and incubated in the dark for 15 min at room temperature. Then the absorbance was measured at 517 nm.
The control was prepared as aforesaid without any sample. The scavenging activity was estimated based on the percentage of DPPH radical scavenged as per the following equation:
Scavenging effect ð%Þ ¼ Control absorbance À Sample absorbance Control absorbance Â 100
Superoxide radical scavenging activity
The superoxide radical scavenging activity was assayed according to the reported method as shown by Nishikimi et al. (1972) , Beauchamp and Fridovich (1971) , and Pithawala and Jain (2014) . Superoxide anions were generated in a phenazine methosulfate-nicotinamide adenine dinucleotide (PMS-NADH) system through the reaction of PMS-NADH and oxygen. It was assayed by the reduction of nitroblue tetrazolium (NBT). All the solutions used in this experiment were prepared in phosphate buffer (pH 7.4). 1 ml of NBT (156 lM), 1 ml of NADH (468 lM) and 1 ml of compound (0-600 lg/ml) were mixed. The reaction was initiated by adding 1 ml of PMS (60 lM) and the mixture was incubated at 25°C for 5 min followed by measurement of absorbance at 560 nm spectrophotometrically. The decreased absorbance of the reaction mixture indicated increased superoxide anion scavenging activity. The percentage inhibition was calculated from the formula, Inhibition ð%Þ ¼ Control absorbance À Sample absorbance Control absorbance Â 100 A percent inhibition versus concentration curve was plotted and the concentration of 4a-4l required for 50% inhibition was determined and expressed as IC 50 value. The lower IC 50 value indicates high antioxidant capacity (Raghavendra et al., 2013) .
ABTS + radical scavenging activity
The 2,2 0 -azinobis (3-ethylbenzthiazoline-6-sulfonic acid), commonly called ABTS + cation scavenging activity was performed (Re et al., 1999) . Briefly, ABTS solution (7 mM) was reacted with potassium persulfate (2.45 mM) solution and kept for overnight in the dark to yield a dark colored solution containing ABTS + radical cations. Prior to use in the assay, the ABTS + radical cation was diluted with 50% DMF for an initial absorbance of about 0.70 ± 0.02 at 745 nm, with temperature control set at 30°C. Free radical scavenging activity was assessed by mixing 300 ll of test sample with 3.0 ml of ABTS working standard in a micro cuvette. Each concentration of sample was taken in range of 0-600 lg/ml as shown in Table 5 . The decrease in absorbance was measured exactly one minute after mixing the solution, and then up to 6 min. The percentage inhibition was calculated according to the formula:
The antioxidant capacity of test samples was expressed as EC 50 (anti-radical activity), the concentration necessary for 50% reduction of ABTS + (Gu¨lc¸in et al., 2011) .
In vitro anti-mycobacterial activity
Here we have performed in vitro anti-mycobacterial activity of all synthesized compounds. Antimicrobial assays performed in Lowenstein Jensen (L-J) medium. Determination of Colony forming units (c.f.u) on Lowenstein-Jensen (L-J) -The tenfold dilution of standard 1 mg/ml M. tuberculosis suspension (Canetti et al., 1969) was streaked on L-J medium for determining c.f.u in the presence and absence of plant extracts. An M. tuberculosis suspension of 1 mg/ml is equivalent to MacFarland standard (Kent and Kubica, 1985) . One loopful (6 ll) of this suspension was streaked on the L-J slants using Novel benzothiazole containing 4H-pyrimido[2,1-b]benzothiazoles derivatives3 mm external diameter loop. Reagents of L-J media included potassium di hydrogen phosphate anhydrous (Qualigens), magnesium sulfate anhydrous (Qualigens), magnesium citrate (Loba Chemie), L-asparagine (Hi-media, Mumbai), glycerol (Fisher Scientific, Mumbai), and malachite green (Hi-Media, Mumbai). The drug was incorporated in the medium at concentration of 2 percent v/v and 4 percent v/v of drug was dissolved into 100 ml of culture medium prior to inspissation. The medium set inoculated with the standard bacterial suspension and incubated at 37°C for 42 days. Reading was taken weekly. For comparison, drug free control slants were used. Susceptibility testing of MDR isolates was also performed against standard drugs such as rifampicin and isoniazid in the same batch of media for comparison of cfu on drug free controls. Each test was done in duplicate. Percentage inhibition was calculated by mean reduction in number of colonies on drug containing as compared to drug free controls.
where c = control, t = test.
Statistical analysis
The determination assay for each antioxidant parameter was carried out in thrice to minimize the percentage of error. Statistical analysis was performed using the Statistical Package for Social Science (IBM SPSS Statistics 20 for Windows, SPSS Inc., Chicago, IL, USA).
Result and discussion
In the present study it has been interpreted and observed that the catalysts have a major role in the organic synthesis, by either enhancing the rate of reaction or any other aspects in pertaining to the reaction. The same has been implemented but however it may not divulge any enhancement in the reaction which could give necessary prediction or their reactions as well. Based on promising result as shown in Table 1 , we have subsequently studied the effect of five solvents DMF (N,N-Dimethylformamide), ACN (Acetonitrile), Methanol, THF (Tetrahydrofuran), DCM (Dichloromethane) and various catalysts (30) in the reaction for the synthesis of 4a from 2-amino benzothiazole 3a as a basic structural configurator along with pyridine 2-aldehyde 1 and ethyl acetoacetate 2 by conventional method. Methanol was used as a solvent for this reaction at 65°C temperature and it gave 46.2% yield in 96 h (entry 34), while the relative yield of 4a is 36.7% in 48 h by using DMF as solvent at 90°C temperature (entry 32). But, to our surprise, we observed that the reaction did not proceed efficiently (Table 1, entries 33, 35-36) in other remaining solvents. The yield and time of product 4a could be improved to 64.8% (1.58 h) when the reaction was performed in DMF at 90°C temperature by using PdCl 2 as catalyst (entry 10). But, the reaction proceeds efficiently when it was carried out under neat condition by conventionally heating for 0.75 h in the presence of PdCl 2 catalyst to afford compound 4a in 75.6% yield (entry 1). InCl 3 is known to have a second catalyst (with 73.2% yield at 1.3 h) of interest from rest of the catalysts used (entry 4). Thus, we conclude that PdCl 2 catalyst and solvent-free condition is the optimized condition for this transformation.
The selected catalyst (PdCl 2 ), was then optimized to work out the maximum yield with minimized reaction time by conventional method. Catalyst loading of 0, 1, 2, 5, 10, 15, and 20 (PdCl 2 mol%) was used. Out of all these varying concentrations, the maximum efficient value was obtained with 10 mol %, as shown in Fig. 1 with maximum yield of 75.6% in 0.75 h of reaction time. The value of yield increases in a gradual fashion, but is known to decrease its value in higher concentrations of catalysts beyond 15 mol%. This might be due to the interference of catalyst. However, it was also noticed to have a fixed reaction time (0.75 h) for the completion of the 4a product as revealed in Table 2 .
By following the same criteria of conventional method, we have carried out the reaction under the CEM discover microwave reactor using an open vessel technique (Dallinger and Kappe, 2007; Stadler and Kappe, 2000; Stadler et al., 2002) for the synthesis of 4a as well as other derivatives (see Scheme 1). In Table 3 , we have shown the comparison of reaction time and yield of product by both conventional and MW methods, comparative aspects with reference to yield and rate of reaction. MW method was found to be better than the conventional one as there is a remarkable reduction in reaction rate. MW is superior in terms of reaction rate, where there is a decrease from 12 to 15 folds and an increase in yield of product from 8% to 10%.
The compound 4a was formed with 85.1% yield in 3 min of reaction time, which was confirmed by different spectroscopic techniques such as IR, 1 H NMR,
13
C NMR, Mass and elemental analysis and X-ray analysis. The IR spectrum of 4a exhibited seven main peaks located at 3072, 2943, 1745, 1677, 1688, 1352, 1240 cm À1 , which were assigned to the (CAH str ) aromatic, (CAH str ) alkanes, (C‚O str ) ester, (C‚C str ) alkene, Scheme 1 Synthetic route for the synthesis of title compounds under solvent-free condition. (C‚N str ) imine, (CAN str ) aromatic amine, and (CAO str ) ester respectively. The mass spectrum of 4a showed a molecular ion peak at ESI-MS: m/z calculated 351.42, found [M+H] + 352.4 which indicates the existence of 4a. The 1 H NMR spectrum of 4a revealed pyridine ring hydrogen (PyAH) peaks shown at 8.59 (1H, dd, J = 7.5, 1.3 Hz, C 6 AH), 7.74 (2H, dtd, J = 9.3, 7.5, 1.6 Hz, C 8&9 AH), 7.42-7.08 (1H, C 7 AH) d value. Chiral center hydrogen resonated at 6.11 d and side chain of ester group contains ACH 2 , ACH 3 shows peak at 4.25, 1.36 d. Also aromatic hydrogens (ArAH) resonated at 7.04 (J = 7.5, 1.4 Hz), 6.73 (J = 11.8, 4.5 Hz) d value.
The structure of compound 4a was also confirmed from single-crystal X-ray diffraction studies. Fine crystals of compound 4a were obtained by slow evaporation of ethyl acetate: hexane (4:1, v/v) mixture with compound 4a. It revealed the formation of pure 4a, which crystallizes as a monoclinic crystal system with a space group P2 1 /n. The results showed the proper structure and configuration as 4a, shown in ORTEP plot (CCDC No.: 1048059) along with the atom numbering in Fig. 2 .
Taking into consideration the entire outcome, a plausible mechanistic pathway for the synthesis of 4a is depicted in Scheme 2.
Antibacterial activity
Antibacterial activity of 4a-4l was carried out on Nutrientagar plates by well-diffusion assay against test culture. Cultures were activated in Nutrient broth. The zone of inhibition was measured in terms of zone diameter and with the help of that zone index was calculated where streptomycin was used as standard.
Determination of activity index
The activity index of the probiotic culture was calculated as follows: Note: Standard drug used was streptomycin with 1000 lg/ml concentration. Table 4 shows that all synthesized derivatives 4a-4l have been screened with antimicrobial activity. Gram negative was more inhibited as compared to Gram Positive bacteria. Also 4c-4g were proved to have more antibacterial property as compared to the streptomycin while contrastingly 4a, 4b, 4j were having a lesser activity index, as shown in Fig. 3 ; however, it could be considered to have antimicrobial activity.
Antioxidant activity
Free radical scavenging activity was evaluated by performing in vitro DPPH assay. As shown in Fig. 4 and Table 5 , % DPPH activity was calculated and it is found that all derivatives 4a-4l have an antioxidant property.
Also the activity is dose dependent in order to scavenge the radical. The higher concentration indicates a greater amount of scavenging of the DPPH radical. The colored DPPH solution faded reducibly to half at an optimal concentration range from 200 lg/ml to 400 lg/ml. This may be induced and influenced due to electron transfer or the reduction of the DPPH molecules or thought to be due to their hydrogen donating ability (Baumann et al., 1979) .
As an indirect indication it may also be a time dependent scavenging activity. As obtained almost all of the derivatives followed a general rule of dose dependent scavenging activity despite the degree of electron transfer. However 4l is known to have a more efficient scavenging property and the least known 4a with a gradual antioxidant property. At higher concentration 4h has a consistent reduction of DPPH scavenging activity to 50% with an optimal concentration range and relatively lesser % scavenging activity rate, as compared to its lower concentration. 4e and 4f showed a constant % scavenging activity following an accuracy as a dose dependent antioxidant reaction.
The scavenging of the ABTS + radical by the derivatives 4a-4l was found to be higher than that of DPPH radical at higher concentration level, indicating that they may be useful as therapeutic agents for treating radical-related pathological Figure 3 Antibacterial activity of 4a-4l.
Figure 4 % DPPH radical scavenging activity assay at various concentrations. Novel benzothiazole containing 4H-pyrimido[2,1-b]benzothiazoles derivativesdamage. DPPH and ABTS + radical scavenging activities are based on the ability of antioxidants to donate a hydrogen atom or an electron to stabilize radicals by converting them to the non-radical species (Binsan et al., 2008; Chandrasekara and Shahidi, 2010) . DPPH is a radical having an odd electron and reacts with hydrogen donated from antioxidant.
In case of ABTS + radical scavenging activity, the effectiveness depends on the molecular weight, the number of aromatic rings and the nature of hydroxyl group's substitution than the specific functional groups (Hagerman et al., 1998) . Superoxide anion scavenging assay at various concentrations in the range of 0-600 lg/ml was evaluated to calculate the IC 50 values of each of derivatives 4a-4l. The IC 50 values were correspondingly in between the range of 280-400 lg/ml. The values correspond to 4a (332 lg/ml), 4b (372 lg/ml), 4c (368 lg/ ml), 4d (316 lg/ml), 4e (344 lg/ml), 4f (300 lg/ml), 4g (390 lg/ml), 4h (281 lg/ml), 4i (301 lg/ml), 4j (285 lg/ml), 4k (321 lg/ml), and 4l (301 lg/ml) respectively as shown in Fig. 5 and Table 6 . ABTS + radical scavenging activity at various concentrations indicated the EC 50 values as 4a (482 lg/ ml), 4b (455 lg/ml), 4c (468 lg/ml), 4d (479 lg/ml), 4e (492 lg/ml), 4f (455 lg/ml), 4g (470 lg/ml), 4h (450 lg/ml), 4i (425 lg/ml), 4j (425 lg/ml), 4k (462 lg/ml), and 4l (405 lg/ ml) respectively as shown in Fig. 6 and Table 7 . This may shed a new horizon in pharmaceutical based drug development and an active drug moiety indicating the increased application of the synthesized compounds.
In vitro anti-mycobacterial activity
In vitro anti-mycobacterial activity showed that all the compounds are bioactive against M. tuberculosis H 37 Rv. From Table 8 , Compounds 4c and 4e showed very good % inhibition 72.9% and 70.32% against M.tuberculosis H 37 RV. Also compounds 4a, 4g, 4j, 4k and 4l exhibited good antimycobacterial activity (% inhibition 67.74%, 68.38%, 60%, 64.51% and 65.80%) against M.tuberculosis H 37 RV. The compounds 4b, 4d and 4h showed moderate to good antimycobacterial activity (% inhibition 58%, 51.61% and 57.41%) against M.tuberculosis H 37 RV. Compounds 4f, displayed less antimycobacterial activity (% inhibition 47.71%) toward M.tuberculosis H 37 RV.
Conclusion
In summary, we have described a novel, efficient, one pot, three component reaction of some typical 2-aminobenzothiazole derivatives, pyridine 2-aldehyde and ethyl acetoacetate to develop ethyl 2-methyl-4-(pyridin-2-yl)-4H-benzo [4, 5] thiazolo[3,2-a]pyrimidine-3-carboxylate derivatives using PdCl 2 as a prompt catalyst under microwave assisted solvent-free conditions. The simple one-pot nature of the reaction makes it an interesting approach. The main advantages of this current methodology are novel with operational simplicity, good yields, simple workup, superficial automation, without any anhydrous conditions. The reactions were carried out under solvent free condition which are considerably safer, nontoxic, and environmental friendly. Furthermore, the existence of three different important heterocyclic moieties such as benzothiazole, pyridine, and pyrimidine rings in one molecule is fantastic on account of the potential applications of these derivatives in biological and pharmacological activities. The synthesized compounds were evaluated in vitro antibacterial and antioxidant activities. The antibacterial data revealed that the all synthesized compounds proved to be active against the test organism, two gram negative and Moreover, all the synthesized compounds were evaluated as antioxidants according to a DPPH radical scavenging activity, superoxide anion scavenging assay and ABTS + radical scavenging activity of our synthesized compound. All compounds showed moderate to good antioxidant activity. We have also screened antitubercular activity against Mycobacterium tuberculosis H 37 RV strain. Compounds 4c and 4e showed very good % inhibition 72.9% and 70.32% respectively against M.tuberculosis H 37 RV and other compound showed moderate to good antitubercular activity. Further optimization and pharmacokinetic characterization of this series are in progress in our laboratory.
